( c ) Recorded to cost of products sold.
(d) Recorded to other, net.
(e) Recorded $176 million to restructuring charges in 2007, $4 million
to selling, general and administrative expenses, $2 million to cost
of products sold, and $2 million to research and development
(f) Amounts are tax effected at the Company's effective tax rate, unless
the amount is a significant unusual or infrequently occurring item
in accordance with FASB Interpretation No. 18, "Accounting for
Income Taxes in Interim Periods.
BOSTON SCIENTIFIC CORPORATION
CONDENSED GAAP RESULTS OF OPERATIONS
In millions, except per share data 2007 2006
Net sales $8,357 $7,821
Cost of products sold 2,342 2,207
Gross profit 6,015 5,614
Selling, general and administrative expenses 2,909 2,675
Research and development expenses 1,091 1,008
Royalty expense 202 231
Amortization expense 641 530
Purchased research and development 85 4,119
Restructuring charges 176
Litigation-related charges 365
Loss on assets held for sale 560
Operating loss (14
|SOURCE Boston Scientific Corporation|
Copyright©2008 PR Newswire.
All rights reserved